SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback